• WNT5a/GSK3/β-catenin Axis Regulates FAP Adipogenesis in Musc

  2026-05-09

  This study elucidates the pivotal role of the WNT5a/GSK3/β-catenin signaling axis in regulating adipogenic differentiation of skeletal muscle fibro/adipogenic progenitors (FAPs). Through integrative pharmacological, cytometric, and transcriptomic approaches, the research identifies actionable targets for limiting detrimental fat infiltration in muscle disease models.

• Topotecan HCl: Precision Drug Response Metrics in Cancer Ass

  2026-05-08

  Explore how Topotecan HCl, a topoisomerase 1 inhibitor, unlocks new precision in evaluating drug responses in cancer research. This article uniquely connects practical assay design with recent insights into measuring proliferation and cell death.

• EZ Cap™ Firefly Luciferase mRNA: Reliable Reporter for Assay

  2026-05-08

  This article explores real-world challenges in cell-based assays and demonstrates how EZ Cap™ Firefly Luciferase mRNA (SKU R1018) offers reproducible, sensitive, and workflow-friendly solutions. Drawing on peer-reviewed data and protocol best practices, we unpack experimental scenarios where Cap 1 structure, optimized poly(A) tailing, and robust performance position this mRNA as a preferred tool for gene regulation and viability assays.

• GPR107 Deficiency Aggravates Diabetic Nephropathy via Ca2+ S

  2026-05-07

  Xu et al. reveal that loss of GPR107 expression in glomerular podocytes intensifies diabetic nephropathy by disrupting collagen IV homeostasis via altered AT1R/Ca2+ signaling. Their mechanistic insights not only clarify podocyte dysfunction in diabetic kidneys but also point to potential molecular targets for future therapies.

• Biotin-16-UTP: Benchmarks in Biotin-Labeled RNA Synthesis

  2026-05-07

  Biotin-16-UTP is a high-purity biotin-labeled uridine triphosphate enabling sensitive RNA detection and purification. Its robust incorporation during in vitro transcription supports RNA-protein interaction studies and advanced lncRNA research. This article summarizes verified performance data, protocol parameters, and misconceptions for optimal laboratory use.

• Deep Learning Detects Cardiotoxicity in iPSC-CM Drug Screens

  2026-05-06

  This study introduces a scalable deep learning approach to identify cardiotoxicity in high-content phenotypic screens using human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs). The workflow demonstrates early detection of drug-induced liabilities, with broad implications for improving drug safety and de-risking therapeutic development.

• COX-2 Pathway's Dual Role in Venom-Induced Muscle Regenerati

  2026-05-06

  This study provides novel evidence for the temporal duality of the cyclooxygenase-2 (COX-2) pathway in skeletal muscle ischemia and revascularization following Bothrops asper venom injury. Through the use of selective COX-2 inhibition, the research demonstrates that early pathway suppression worsens ischemia, while delayed inhibition enhances angiogenic signaling—offering important mechanistic insights for muscle regeneration models.

• TAK1-YAP Axis Regulates Gastric Cancer Stem Cell Self-Renewa

  2026-05-05

  This study uncovers how TGFβ-activated kinase 1 (TAK1) stabilizes yes-associated protein (YAP), promoting the self-renewal and oncogenicity of gastric cancer stem cells. The work illuminates a critical regulatory mechanism and provides a molecular framework for future research aimed at targeting gastric cancer stemness and therapy resistance.

• Fludarabine: DNA Synthesis Inhibitor for Oncology Research

  2026-05-05

  Fludarabine stands out as a robust DNA synthesis inhibitor, enabling precise cell cycle and apoptosis studies in leukemia and multiple myeloma research. This article covers in-depth protocols, advanced applications, troubleshooting strategies, and actionable insights from current literature—making APExBIO's Fludarabine a preferred choice for translational workflows.

• Combination Nuclear Export Inhibition in Basal-like TNBC Mod

  2026-05-04

  This study systematically identifies nuclear export inhibitor-based drug combinations, focusing on KPT-330 (Selinexor), as synergistic therapies for basal-like triple-negative breast cancer (TNBC). The integration of high-throughput screening, patient-derived xenografts, and transcriptomic analysis highlights XPO1 overexpression as a targetable vulnerability, providing robust preclinical evidence for combination strategies in aggressive TNBC.

• Decoding Heme Pathways: 5-ALA HCl in Infection & Cancer Rese

  2026-05-04

  This thought-leadership article explores the mechanistic and translational significance of 5-Aminolevulinic acid HCl as a critical intermediate in heme biosynthesis, with a focus on immune evasion in bacterial pathogens and cancer research applications. By integrating insights from landmark studies and APExBIO’s product innovation, the piece offers strategic guidance for researchers advancing from molecular mechanisms to clinical translation.

• Cefazedone (Refosporen): Applied Protocols and Troubleshooti

  2026-05-03

  Cefazedone (Refosporen) stands out for its β-lactamase-resistant, broad-spectrum efficacy in both Gram-positive and Gram-negative bacterial models. This article delivers actionable workflows, protocol refinements, and troubleshooting strategies rooted in recent comparative studies—empowering translational researchers to maximize data reliability and clinical relevance.

• Difloxacin HCl: Quinolone Antimicrobial Antibiotic in Resear

  2026-05-02

  Difloxacin HCl stands out as a quinolone antimicrobial antibiotic with dual utility in both in vitro antimicrobial susceptibility testing and multidrug resistance reversal. APExBIO’s high-purity formulation empowers researchers to confidently probe both infectious disease and oncology workflows, with proven stability, solubility, and workflow flexibility.

• DDI2-NFE2L1 Axis: Proteasome Activation Shields Against Ferr

  2026-05-01

  This study reveals how activation of the DDI2-NFE2L1 pathway restores proteasome function and protects cells from ferroptosis, an iron-dependent form of cell death. The findings identify DDI2-mediated NFE2L1 activation as a critical adaptive response and suggest new targets for sensitizing cancer cells to ferroptosis-based therapies.

• Ribonuclease R (20 U/μL): Precision in Circular RNA Enrichme

  2026-05-01

  Ribonuclease R (RNase R) (20 U/μL) enables robust circular RNA enrichment by selectively digesting linear RNA, making it indispensable for advanced RNA metabolism and structure-function studies. This guide translates cutting-edge research into actionable protocols, troubleshooting insights, and workflow enhancements for reliable circular RNA analysis.

15827 records 1/1056 page Next 12345 下5页 Last page